Table 1 Patient characteristics.
Characteristics | N = 34 (%) | ||
|---|---|---|---|
Age | Median (years) (range) | 64.5 | (41–80) |
Sex | Male | 23 | (68) |
Female | 11 | (32) | |
ECOG PS | 0 | 20 | (59) |
1 | 13 | (38) | |
2 | 1 | (3) | |
Site of primary tumour | Right-sided colona | 4 | (12) |
Left-sided colorectumb | 30 | (88) | |
Prior resection of the primary tumour | Yes | 25 | (74) |
No | 9 | (26) | |
Metastatic sites | Liver | 29 | (85) |
Lung | 14 | (41) | |
Peritoneum | 8 | (24) | |
No. of metastatic sites | 1 | 9 | (26) |
2 or 3 | 19 | (56) | |
≥4 | 6 | (18) | |
First-line Tx | Oxaliplatin-based | 19 | (56) |
Irinotecan-based | 15 | (44) | |
Best overall response in first-line Tx | CR | 0 | 0 |
PR | 29 | (85) | |
SD | 5 | (15) | |
Second-line Tx | Oxaliplatin-based | 15 | (44) |
Irinotecan-based | 19 | (56) | |
Bevacizumab | 33 | (97) | |
Best response in second-line Tx | PR | 5 | (15) |
SD | 27 | (79) | |
PD | 2 | (6) | |
